Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8144
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers herbal tea, Chinese and Western medicine, intermediates, and others. It also offers services such as research and development, and manufacturing and sales of Chinese and Western patent medicine. Guangzhou Baiyunshan Pharmaceutical provides chemical active pharmaceutical ingredients (API), biological medicine and chemical API intermediates. The company is also engaged in import and export business, medical care, health management, and health industry investment. Guangzhou Baiyunshan Pharmaceutical is headquartered in Guangzhou, China.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Guangzhou Baiyunshan Pharma Forms Joint Venture with Zhejiang Angli Kang Pharma 10
Guangzhou Baiyunshan Pharma Plans To Form Joint Venture With Ferid Murad 11
Equity Offering 12
Guangzhou Baiyunshan Pharma Raises USD1.28 Billion in Private Placement of Class A Shares 12
Acquisition 14
Guangzhou Baiyunshan Pharma to Acquire 30% Stake in Guangzhou Pharma from Walgreens Boots Alliance 14
Guangzhou Baiyunshan Pharma to Acquire Guangzhou Pharmaceutical Research Institute from Guangzhou Pharmaceutical Holdings 15
Guangzhou Pharmaceutical Completes Acquisition Of Guangzhou Baiyunshan Pharmaceutical For US$859.4 Million 16
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Key Competitors 17
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Key Employees 18
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Affiliate 19
Joint Venture 19
Recent Developments 21
Financial Announcements 21
Sep 10, 2018: Baiyunshan released half year report, profits up 115.02% 21
Government and Public Interest 23
Jul 07, 2018: GPHL’s chairman and delegation attend 24th Lanzhou Investment & Trade Fair 23
Other Significant Developments 24
Aug 07, 2018: Ethiopian Consul-General in Guangzhou visited GPHL 24
Jul 16, 2018: Shanghai Pharmaceuticals chairman visits GPHL with delegation 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Baiyunshan Pharma Forms Joint Venture with Zhejiang Angli Kang Pharma 10
Guangzhou Baiyunshan Pharma Plans To Form Joint Venture With Ferid Murad 11
Guangzhou Baiyunshan Pharma Raises USD1.28 Billion in Private Placement of Class A Shares 12
Guangzhou Baiyunshan Pharma to Acquire 30% Stake in Guangzhou Pharma from Walgreens Boots Alliance 14
Guangzhou Baiyunshan Pharma to Acquire Guangzhou Pharmaceutical Research Institute from Guangzhou Pharmaceutical Holdings 15
Guangzhou Pharmaceutical Completes Acquisition Of Guangzhou Baiyunshan Pharmaceutical For US$859.4 Million 16
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Key Competitors 17
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Key Employees 18
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Subsidiaries 19
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Affiliate 19
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Joint Venture 19

List of Figures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ana Holdings Inc
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Option Care Health Inc (OPCH):企業の財務・戦略的SWOT分析
    Option Care Health Inc (OPCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Belfius Bank SA:企業の戦略・SWOT・財務情報
    Belfius Bank SA - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Operation Technology Inc:企業の戦略的SWOT分析
    Operation Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Deep Down Inc (DPDW):企業の財務・戦略的SWOT分析
    Summary Deep Down Inc (Deep Down) is a subsea oilfield services company that offers exploration and production support products and services. The company provides products such as active heave compensator, asset wellness, bend limiters, bend stiffener latcher, buoyancy modules, carousels, dynamic po …
  • AutoZone, Inc.:企業の戦略・SWOT・財務情報
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Celon Pharma SA (CLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Celon Pharma SA (Celon Pharma), subsidiary of Glatton Sp zoo, is an integrated pharmaceutical company that carries out research and develops new medicines. The company provides product portfolio such as Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel, among others. It pri …
  • Schweitzer-Mauduit International Inc (SWM):企業の財務・戦略的SWOT分析
    Schweitzer-Mauduit International Inc (SWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • InteRNA Technologies BV:製薬・医療:M&Aディール及び事業提携情報
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that develops RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs offers developing miRNA-based therapeutics that c …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • Norton Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Norton Healthcare Inc (Norton Healthcare) is a healthcare service provider that offers medical services. The center offers services such as cancer care, bariatric and weight management, diabetes and endocrine, gastroenterology, clinical trials, pain management, bone marrow transplantation, d …
  • Legacy Reserves LP (LGCY):石油・ガス:M&Aディール及び事業提携情報
    Summary Legacy Reserves LP (Legacy Reserves) is an oil and gas exploration and production company that acquires and develops oil and natural gas properties in the Permian Basin, Mid-Continent and Rocky Mountain regions of the US. The company provides Permian Basin which is an oil and natural gas pro …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Secom Co Ltd (9735):企業の財務・戦略的SWOT分析
    Secom Co Ltd (9735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆